ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD
ES3079237T3 · Publication stage not classified
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name Astellas US LLC.
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
ES3079237T3 · Publication stage not classified